{"name":"Critical Biologics Corporation","slug":"critical-biologics-corporation","ticker":"","exchange":"","domain":"","description":"Critical Biologics Corporation is a biotechnology company focused on the development of innovative therapeutic proteins. The company's lead candidate, rhu-pGelsolin, is currently in Phase 1 clinical trials. Limited financial and operational data is available.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNS1Z4SU9Wc1oyU2NvcUVvMkZIRUV4bGl3aFZSZHdwNzVkVXdqMi00VnZPLTRoRmxPUTV1NmdmX3g5NV8yMFRWbTJDTWU0U2h1QkdZZjRyc1NFN194c1d2THpNZGhiS09KX05WZmVUTGFVWk1FZkp5bmY2NUtnS0Q5bGIxSlB1cVhwdHBnb19VUEJHZjRvenR3dkdtRDA2WWtMSVZ1QXRjRDRFWW9HanVuSVlZTFNCZ01LOHZRMjlBcWFBWlVBSlE?oc=5","date":"2026-04-05","type":"pipeline","source":"IndexBox","summary":"Pharmaceutical Intermediates Market Analysis 2026-2035: Growth Drivers and Regional Outlook - News and Statistics - IndexBox","headline":"Pharmaceutical Intermediates Market Analysis 2026-2035: Growth Drivers and Regional Outlook - News and Statistics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPTThXMXVRUDVJN1g1cWE0S1FFcGQtVWJUR0lKbkE3UmMwNkRRaXhJWjZaZ0EtZF96Smp2TU1EZUhhMWNjOHRUa1I2eFZVU1F1Z2R2V0UwNzRGWnp1OGxVVmR4YXU2NVBYYTktalhjT1dSekdRTk90cTRNVnNWeEdIamtMT05VTUlFaTFiYzcweThXdVJxZ3hRRkxCZmYwc01ZZkF2dFRzWXhLZEF6cHFELXVUeGIxeGVRcUtCeg?oc=5","date":"2026-04-01","type":"pipeline","source":"TradingView","summary":"WST Expands Dublin Facility to Boost Injectable Therapy Capacity - TradingView","headline":"WST Expands Dublin Facility to Boost Injectable Therapy Capacity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPQ29vM3ZmdjJaajlNZ01Kb3Z0Umo3NmtWMHhZaWc2WDZiZ29vaktfTUxCRGtVYkN5N0JpNTFoYXd3a0pxQXVIZUxPMDBIWjJMMG9WLU9oYzNZTUw4UWxHdTgwcGFzZHBxTXNJckRDQVdHcVpXTkFnRzN1SGg4OVV4bklDMF9fNU00cDVtaDFWRTNleEVYQ1Q3aUxNS25fZjdlTFVUd2d0MDN6UmlNWGVCSVpoejR0TU5mU2pYU0lHRlJ3OUpIOEdEdGFwWHJXU2tKOERCeDhuaVp0X0U4RjljYlNKQThaZ0NEcHNTRA?oc=5","date":"2026-03-31","type":"pipeline","source":"IndexBox","summary":"World Polyolefin In Pharmaceutical Packaging - Market Analysis, Forecast, Size, Trends and Insights - IndexBox","headline":"World Polyolefin In Pharmaceutical Packaging - Market Analysis, Forecast, Size, Trends and Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOR1NTc01QZGJBVDRpTlBLckVMNVp0dHcxLWZoR2pDWldMbEkycEgzMHpRTjQ5cUdjd0I4U2VPUzdHTVo4dFdOaTZGLXd2eTRNRkdtaXZuQjhVUUhKZmV0T1Y2Y1EtaWhqdy1BcUc4U2VUTmQtZEd6OTJkbno4SWlFcW1Hd1ROdnE2TF8weElfcE1qWjFXMUg2S3lWZGluX0thVW1TaWgxMmIxZGsxZzQ4bXc5SzZPRnQ2cUtzZzdKaVhKMVk?oc=5","date":"2026-03-26","type":"patent","source":"Fierce Pharma","summary":"Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab - Fierce Pharma","headline":"Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQaUxFTWlZb0hUbXlJTktZNkl5S0ZRSG5oOEpBam0xa1F6SGE3U2dISWE4U2k2Rm5ZYjdPV2xpczZJQmV6WU1YVnNaTURxRTUyZHhCd0dhYXZpQkdSNHE0SndtQldjTkFQOS1Bdk9RRXlOb3dHSTNvdEdZVmlmQ0ZYWVZ3ZTdaVHY1WG9qYTZoS1JrMUhJZGxOZUJDZFRUeC15UWt4ZQ?oc=5","date":"2026-03-25","type":"pipeline","source":"European Medical Journal","summary":"The Middle East conflict: pharma’s supply chain stress test - European Medical Journal","headline":"The Middle East conflict: pharma’s supply chain stress test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxONG1OLUhiT0VNNXQtZ0xyZzBlU00zZkp5dmlLdUlZUjVjQlphQUdqLWFqX2IyUGhoREZFX2NYY1lnbkZEcTlKdmE1MUFVVkdMLTZIdjZwZHYzZUZ2ZzdKTVJNVGVvSDhIVTNmSU9SNlc0dUppSkZYZzVaY2YxS3hRNnRGTmxscG1hYmQ0VGhONjBJOVJ1YjJQenM2cXRZZGVHVktPVEhIZzBfb3NmUkpMYkJiSm80RGZOa21kdA?oc=5","date":"2026-03-01","type":"regulatory","source":"The Globe and Mail","summary":"Xenon awaiting critical epilepsy drug study results that could lead to FDA approval - The Globe and Mail","headline":"Xenon awaiting critical epilepsy drug study results that could lead to FDA approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNRThqaTZNU0hSZFNDUUVwUEFOaDZtM1JVNDBSX0pLb1VaRV96Ym5SeUxGUzhVYjQtZUp6WU5hdko3VEtKLXRzTEl4SFMzRlRrZ1hMd2ltTmpoc210U1hkREthLTJWNTZpekI4YzdoVy03d21oWTlLcmpseHdlclFSMDZRM20yUlg2cmd6d2FINEN3N2NRZmxSc2gtUU5mbFhSVHROa25B?oc=5","date":"2025-12-22","type":"deal","source":"Contract Pharma","summary":"Samsung Biologics Acquires Human Genome Sciences from GSK - Contract Pharma","headline":"Samsung Biologics Acquires Human Genome Sciences from GSK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQRlBUdTh2aUtITXNiMkxzSW9rampEOHJZNGhLWmdMSkxydFFGQkdkcUIxckc0QnNSN29WdGhPYXJRR1ZESVhhdlFZX0JROWJUd2RXZ0xCYmlCcjJfNkZpVUZtUDU1VVVIc2pxX1h2c0NpZ3pxY0ROSUw2OVV3c2hNOU04VkdLRXRITEg1TnQ2YlhQLWdKMkJtaVBhNWp5RnhwUWFhN3k3ZWwtdFFCQko2bQ?oc=5","date":"2025-11-18","type":"regulatory","source":"Pharmaceutical Technology","summary":"FDA inspection reveals critical supply chain vulnerabilities - Pharmaceutical Technology","headline":"FDA inspection reveals critical supply chain vulnerabilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPOHJxSndlNmgwMGlwdnlGeDB0ak9tWWtJMEllT0hCTzU4OGFiS3B2QmEyZnVPUkIwOXZTZmp5SkYtQmkzd0trbXhia2sxQkRsNFl6TEZQTEVzNDNNQ3lJNE95N2lwZnA5YjZ1QUtVQVVrOU1DeVk5QXNMQVZGaUZvNVVnOVZpZlh4QTdRQWt6bnFwOF9vZU1zemZtbTlGajU4NFZsbU5FenpVNHlHSFNFY2haa1BQRkh4NzVYbWhxMm5BZWJRQjhTVTh4STl4ZnJ2NHlha0J5elVYZl83?oc=5","date":"2025-10-30","type":"pipeline","source":"PharmaLive","summary":"$350 billion U.S. pharmaceutical manufacturing investment boom challenged by labor shortages, tariffs, and policy shifts - PharmaLive","headline":"$350 billion U.S. pharmaceutical manufacturing investment boom challenged by labor shortages, tariffs, and policy shifts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPWTRFOUppbS1xeEZoUkQ1UmZCVU1YNEtrS29DajFhMWM0a0NrSjl4NTFXSmIweG5uNHhrVjNKcVFVVEZYbEhJbkRXeXRUT3JmMWR3SGlHTk05NHNhWDhiYTY3blAtNWJpc2MwYjF3aTIwb3ZmeWRjcUlnVzFvVnZyZUhTUmZPZlhDWDlrV214UTROT0tTMjFiQWZlU2V6OVZvQS1rZS1GdEVXNEdWRFFCVzJQVGZRcFRxbUtCM2pZcmphb3FDVV9EdGJFenNEQnlfNnA1RDdvLUNiN0ZBSlktSXRn?oc=5","date":"2025-09-30","type":"pipeline","source":"Investing News Network","summary":"AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S. - Investing News Network","headline":"AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5WUEd5aVRIRER2R0FjOWctWnVUc1BFV3BlWmpzbUVmeDRqMkpkRDFUM1hOMEIteEZzTHlDMFBCeTBmbElhb0RlbzVHazl2aDNkNWtTdFFPYUM2elhVZVJTUThhcl9LQVJFc3pVbzFR?oc=5","date":"2025-08-20","type":"pipeline","source":"Pharmaceutical Executive","summary":"Driving Disruption in Delivery - Pharmaceutical Executive","headline":"Driving Disruption in Delivery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQVEZRQ3FEak94V0MyMV9xNU5iNHE5RGw0OXhCTmp1YWh2WVU2MFA0cXIyaEhpZTZHQ29Cai1XTnpqTW5HeC1SaFFYcHdSamhQODY0S3FOOUk1T3NnRUxrbFlDQ2VfQVhTWGswUmJUUVpQeXJzWHY1UlkxOGtfZ056WUdLdktxV3JCOFkyTy1FTU9BbHZXX2xuVzV2TzdPdXZmckJMNUFicDM5eGhmMkQ4aXBOX0l2R3VZX05vbXkyemNDZzloc2otMHhESTd0RHM1QUE?oc=5","date":"2025-06-20","type":"deal","source":"McKinsey & Company","summary":"Pulse check: Key trends shaping biopharma dealmaking in 2025 - McKinsey & Company","headline":"Pulse check: Key trends shaping biopharma dealmaking in 2025 - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}